Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest this time around. We plan to hang with Mrs. Pharmalot, catch up on our growing reading list, and hopefully mellow out. And what about you? Autumn is nearly here, so why not forage for a few apples or take a long drive to enjoy the great outdoors. You could tune out the world, such as it is, with a good book. Or make time for someone special. The possibilities are endless. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Senate Republicans are warning Speaker Nancy Pelosi that her much-anticipated drug pricing plan is dead and will not be considered in the Senate, Politico confides. Senate Majority Leader Mitch McConnell (R-Ky.) ruled out any action on the bill, which would call for Medicare to negotiate drug prices for a minimum of 25 medicines and target drugs that cost the American health system the most. Pelosi rolled out the plan on Thursday to intense opposition from the drug industry — and McConnell.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.